The medicine shortage reports database includes information about shortages of reportable medicines in Australia, including those arising from the discontinuation of products.
You can use this page to search for all medicines in shortage and find information about management actions, including supply of overseas alternative medicines.
Information in this database is based on details reported to us by sponsors. Any additional management actions taken by us will be clearly stated.
How to search
The database defaults to all current medicine shortages. You can also view anticipated and resolved shortages and discontinuations.
To search the database for all shortages and discontinuations for a particular medicine, type the active ingredient or trade (brand) name into the search field. You can then click on the active ingredient name or trade name for more information about the shortage of interest.
You can also download an extract of all shortages and discontinuations.
To view all medicines shortages and discontinuations with a critical shortage impact rating, click on the CRITICAL medicine shortages link below.
Further information
Information about medicine shortages is available at the Medicine Shortages hub
Subscribe to Medicine Shortages updates
You can subscribe to Medicine Shortages Email Alerts or the Medicine Shortages RSS feed for frequently updated information.
This service does not support Internet Explorer 7 and below.
Search Results
Browse CRITICAL shortages and discontinuations
Click here to display ALL medicine shortages and discontinuations
AUST R: 14332
Expected supply: 31 Dec 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. Please contact the approval holder for details on supply: Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific - Ph: 02 9503 8100
Updated: 29-11-2022
phenoxybenzamine hydrochloride
AUST R: 12980
Expected supply: 30 Jun 2024
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 21-06-2023
AUST R: 161298
Expected supply: 31 May 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 29-03-2023
dantrolene sodium hemiheptahydrate
DANTRIUM dantrolene sodium hemiheptahydrate 25mg capsule bottle
AUST R: 42975
Expected supply: 31 Dec 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 17-06-2022
AUST R: 18695
Expected supply: 31 May 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 29-03-2023
AUST R: 18770
Expected supply: 31 May 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 29-03-2023
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)
ONCOTICE BCG 5 hundred million CFU powder for injection vial
AUST R: 59912
Expected supply: 31 Dec 2024
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 07-03-2022
CIPLA BLEOMYCIN 15K bleomycin sulfate 15000 IU powder for injection vial
AUST R: 220440
Expected supply: 30 Sep 2023
Availability: Unavailable
Management action: Supply of an alternative product is under consideration.
Updated: 29-03-2023
ETHYOL Amifostine (as trihydrate) 500mg powder for injection vial
AUST R: 63789
Expected supply: 31 Jul 2024
Availability: Unavailable
Management action: Alternative unapproved products available under the Special Access Scheme
Updated: 25-07-2023
SYNACTHEN DEPOT tetracosactide (tetracosactrin) zinc complex 1mg/1m L injection ampoule
AUST R: 11060
Expected supply: 30 Nov 2023
Availability: Unavailable
Management action: Alternative unapproved products available under the Special Access Scheme (SAS). For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme
Updated: 15-11-2022
CILICAINE SYRINGE 1.5 procaine benzylpenicillin (procaine penicillin) 1.5g injection syringe
AUST R: 288818
Expected supply: 31 Dec 2022
Availability: Unavailable
Updated: 14-12-2022
HYDRALAZINE LINK hydralazine hydrochloride 20 mg/1 mL solution for injection vial
AUST R: 272644
Expected supply: Unknown
Availability: Unavailable
Management action: Alternative brand available
Updated: 28-03-2023
AUST R: 235933
Expected supply: 30 Jun 2024
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 26-07-2023
CARBOSORB XS activated charcoal 50 g/250 mL and sorbitol 70.75 g/250 mL suspension bottle
AUST R: 307429
Expected supply: 31 Jan 2024
Availability: Unavailable
Management action: Sponsor is working to expedite the next shipment.
Updated: 27-03-2023
dexamethasone sodium phosphate
DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 4mg/1mL (as sodium) injection ampoule
AUST R: 16374
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: An alternate presentation of the same strength is available.
Updated: 16-02-2023
adrenaline (epinephrine) acid tartrate
XYLOCAINE 0.5% WITH ADRENALINE 1:200,000 20mL injection vial
AUST R: 12008
Expected supply: 01 Apr 2024
Availability: Unavailable
Management action: Other strengths available.
Updated: 24-08-2023
TOFRANIL 25 imipramine hydrochloride 25mg tablet blister pack
AUST R: 60673
Expected supply: 31 Dec 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 16-01-2023
AUST R: 81930
Expected supply: 30 Apr 2024
Availability: Unavailable
Updated: 17-03-2023
AUST R: 81931
Expected supply: 30 Apr 2024
Availability: Unavailable
Updated: 17-03-2023
dexamethasone sodium phosphate
AUST R: 163200
Expected supply: 30 Nov 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Alphapharm Pty Ltd can be contacted on 1800 274 276 for details on supply.
Updated: 04-09-2023
METALYSE tenecteplase (rch) 50mg powder for injection vial plus prefilled syringe
AUST R: 75013
Expected supply: 31 Dec 2024
Availability: Limited Availability
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse. The TGA has approved a shelf-life extension of an additional 12 months from the original expiry date on the packaging for Metalyse batches with an original expiry date from January 2022 up to March 2025.
Unregistered alternative products have been approved for supply under Section 19A. For information on supply, contact the approval holders: Pro Pharmaceuticals Group Pty Ltd (Phone: 1300 077 674) or Medsurge Healthcare Pty Ltd (Phone: 1300 788 261).
Updated: 17-08-2023
AUST R: 13537
Expected supply: Unknown
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
Updated: 06-03-2023
adrenaline (epinephrine) acid tartrate
ADRENALINE-LINK 1:10,000 1mg/10mL adrenaline (epinephrine) acid tartrate injection BP ampoule
AUST R: 119194
Expected supply: Unknown
Availability: Unavailable
Updated: 27-01-2023
AUST R: 49422
Expected supply: 31 Jan 2024
Availability: Unavailable
Management action: An unregistered alternative product has been approved for supply under Section 19A. The approval holder, Guerbet Australia Pty Ltd can be contacted on 02 8075 3007 for details on supply
Updated: 08-05-2023
AUST R: 47997
Expected supply: 31 Jan 2024
Availability: Unavailable
Management action: An unregistered alternative product has been approved for supply under Section 19A. The approval holder, Guerbet Australia Pty Ltd can be contacted on 02 8075 3007 for details on supply
Updated: 08-05-2023
DBL VANCOMYCIN vancomycin (as hydrochloride) 500mg powder for injection vial
AUST R: 62603
Expected supply: Unknown
Availability: Unavailable
Management action: An alternative brand is available
Updated: 21-11-2022
DBL LEUCOVORIN CALCIUM folinic acid 15 mg/2mL (as calcium folinate) injection ampoule
AUST R: 16351
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternate strengths available
Updated: 08-06-2022
METALYSE tenecteplase (rch) 40mg powder for injection vial plus prefilled syringe
AUST R: 75012
Expected supply: 31 Dec 2024
Availability: Limited Availability
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse. The TGA has approved a shelf-life extension of an additional 12 months from the original expiry date on the packaging for Metalyse batches with an original expiry date from January 2022 up to March 2025.
Unregistered alternative products have been approved for supply under Section 19A. For information on supply, contact the approval holder, Pro Pharmaceuticals Group Pty Ltd on 1300 077 674
Updated: 17-08-2023
ACTILYSE alteplase (rch) 50 mg powder for injection vial with diluent vial
AUST R: 17905
Expected supply: 31 Dec 2023
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply. A TGA web statement is available at https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse.
Updated: 13-02-2023
ACTILYSE alteplase (rch) 10mg powder for injection vial with water for injections 10mL vial
AUST R: 64240
Expected supply: 31 Dec 2023
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply. A TGA web statement is available at https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse.
Updated: 27-01-2023
AUST R: 223583
Expected supply: 31 Jan 2024
Availability: Unavailable
Management action: Other strength available.
Updated: 25-07-2023
DBL CIPROFLOXACIN 200 mg/100 mL injection for intravenous infusion bag
AUST R: 123041
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic product is available
Updated: 11-09-2023
DBL CIPROFLOXACIN 400 mg/200 mL injection for intravenous infusion bag
AUST R: 123042
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Updated: 06-07-2023
MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial
AUST R: 316671
Expected supply: 26 Dec 2022
Availability: Available
Management action: The sponsor is closely controlling the supply and working to expedite the next shipment.
Updated: 03-11-2022
HEPARIN SODIUM 5000IU/5mL (porcine mucous) injection ampoule
AUST R: 49232
Expected supply: 29 Mar 2024
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Orspec Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
Updated: 04-08-2023
TECHNESCAN HDP kit for preparation of Technetium [99mTc] oxidronate powder for injection vial
AUST R: 75500
Expected supply: 22 Jun 2023
Availability: Available
Updated: 27-06-2023
VANCOMYCIN JUNO vancomycin (as hydrochloride) 1 g powder for injection vial
AUST R: 330502
Expected supply: 05 Dec 2023
Availability: Unavailable
Management action: Alternative generic products are available
Updated: 23-08-2023
Pfizer (Australia) METRONIDAZOLE 5mg/mL (0.5%) injection vial
AUST R: 12728
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic products are available.
Updated: 24-11-2022
DBL VANCOMYCIN vancomycin (as hydrochloride) 1000 mg powder for injection vial
AUST R: 62595
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: An alternative brand is available
Updated: 14-12-2022
suxamethonium chloride dihydrate
SUXAMETHONIUM JUNO suxamethonium chloride dihydrate 100 mg/2 mL injection ampoule
AUST R: 320687
Expected supply: 31 Dec 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 27-06-2023
phenoxymethylpenicillin potassium
AUST R: 159753
Expected supply: 06 Sep 2023
Availability: Available
Updated: 06-09-2023
phenoxymethylpenicillin potassium
AUST R: 159754
Expected supply: 06 Sep 2023
Availability: Available
Updated: 06-09-2023
phenoxymethylpenicillin benzathine
CILICAINE V phenoxymethylpenicillin (as benzathine) 150mg/5mL oral liquid, suspension bottle
AUST R: 151598
Expected supply: 30 Jun 2023
Availability: Available
Updated: 05-07-2023
CARBOSORB X activated charcoal 50 g/250 mL suspension bottle
AUST R: 106470
Expected supply: 19 Jul 2023
Availability: Available
Updated: 26-07-2023
AUST R: 73173
Expected supply: 12 Jul 2023
Availability: Available
Updated: 12-07-2023
HEPARINISED SALINE 50IU/5mL (porcine mucous) injection ampoule
AUST R: 66684
Expected supply: 23 Aug 2023
Availability: Available
Updated: 23-08-2023
AUST R: 46451
Expected supply: 22 Dec 2023
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
Updated: 28-07-2023
AUST R: 144970
Expected supply: 31 Dec 2024
Availability: Unavailable
Management action: Other brands are available.
Updated: 11-08-2023
AUST R: 150021
Expected supply: 30 Oct 2023
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
An alternative dosage form is available - Sabril Powder Oral Sachet ARTG 52985
Updated: 21-08-2023
AUST R: 16290
Expected supply: 17 Jul 2023
Availability: Available
Updated: 17-07-2023
GLUCAGEN HYPOKIT glucagon (rys) 1mg (1IU) powder for injection vial with diluent syringe
AUST R: 47105
Expected supply: 30 Sep 2023
Availability: Limited Availability
Management action: A TGA web alert is available at: https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/shortage-glucagen-hypokit-glucagon. Unregistered products have been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 04-08-2023
naloxone hydrochloride dihydrate
DBL NALOXONE HYDROCHLORIDE 400 microgram/1mL injection USP ampoule
AUST R: 16282
Expected supply: 20 Oct 2023
Availability: Unavailable
Management action: Alternative generic products are available
Updated: 11-09-2023
AUST R: 337517
Expected supply: 28 Aug 2023
Availability: Available
Updated: 28-08-2023
AUST R: 14328
Expected supply: 10 Jul 2023
Availability: Available
Updated: 10-07-2023
GENTECH 0.9% W/V SODIUM CHLORIDE INJECTION BP sodium chloride 90mg/10mL injection vial
AUST R: 79842
Expected supply: 09 Aug 2023
Availability: Available
Updated: 10-08-2023
GENTECH 0.9% W/V SODIUM CHLORIDE INJECTION BP sodium chloride 45mg/5mL injection vial
AUST R: 79845
Expected supply: 09 Aug 2023
Availability: Available
Updated: 10-08-2023
CYMEVENE ganciclovir 500mg (as sodium) powder for injection vial
AUST R: 10047
Expected supply: 06 Nov 2023
Availability: Available
Management action: Sponsor is working to expedite the next shipment.
Updated: 28-06-2023
AUST R: 276671
Expected supply: 31 Dec 2023
Availability: Unavailable
Management action: Alternate product available via Special Access Scheme (SAS).
Updated: 07-07-2023
SYNAREL NASAL SPRAY nafarelin 2mg/mL (as acetate) spray solution aerosol pump actuated metered dose
AUST R: 48127
Expected supply: 25 Jul 2023
Availability: Available
Updated: 25-07-2023
AUST R: 79745
Expected supply: 20 Sep 2023
Availability: Available
Updated: 21-09-2023
naloxone hydrochloride dihydrate
NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial
AUST R: 309381
Expected supply: 13 Oct 2023
Availability: Emergency Supply Only
Management action: Sponsor is working to expedite the next shipment.
An unregistered product has been approved for supply under Section 19A. The approval holder Pro Pharmaceuticals Group can be contacted on 1300 077 674 for details on supply
Updated: 16-08-2023
Pertussis filamentous haemagglutinin
AUST R: 158363
Expected supply: 18 Dec 2023
Availability: Only available under NIP or government programs
Management action: Alternative products are available
Updated: 25-08-2023
DBL LEUCOVORIN CALCIUM folinic acid 50 mg/5 mL (as calcium folinate) injection USP vial (NF)
AUST R: 42148
Expected supply: 26 Jan 2024
Availability: Available
Management action: Alternative brand available.
Updated: 22-08-2023
AUST R: 313549
Expected supply: 08 Sep 2023
Availability: Available
Updated: 08-09-2023
VOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe
AUST R: 376616
Expected supply: 31 Jul 2023
Availability: Available
Updated: 02-08-2023
DBL GEMCITABINE INJECTION gemcitabine (as hydrochloride) 2g/52.6mL solution for Injection vial
AUST R: 160204
Expected supply: 05 Jul 2023
Availability: Available
Updated: 05-07-2023
AUST R: 52985
Expected supply: 27 Jul 2023
Availability: Available
Updated: 27-07-2023
VOXZOGO vosoritide 0.56 mg powder for injection vial and diluent pre-filled syringe
AUST R: 376617
Expected supply: 31 Jul 2023
Availability: Available
Updated: 02-08-2023
VOXZOGO vosoritide 1.2 mg powder for injection vial and diluent pre-filled syringe
AUST R: 376618
Expected supply: 31 Jul 2023
Availability: Available
Updated: 02-08-2023
AUST R: 337516
Expected supply: 28 Aug 2023
Availability: Available
Updated: 28-08-2023
AUSTRAPEN ampicillin 1g (as sodium) powder for injection vial
AUST R: 29354
Expected supply: 30 Oct 2023
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 15-09-2023
DBL LEUCOVORIN CALCIUM folinic acid 300 mg/30 mL (as calcium folinate) injection vial
AUST R: 116688
Expected supply: 31 Jan 2024
Availability: Unavailable
Management action: Sponsor is working to expedite the next shipment.
Updated: 29-08-2023
sodium thiosulfate pentahydrate
AUST R: 133490
Expected supply: 31 Jan 2024
Availability: Limited Availability
Management action: Alternative generic product is available
Updated: 23-08-2023
ALLMERCAP mercaptopurine monohydrate 20mg/mL oral liquid suspension bottle
AUST R: 213881
Expected supply: 28 Aug 2023
Availability: Available
Updated: 01-09-2023
PRIMAXIN imipenem 500mg and cilastatin 500mg (as sodium) powder for injection vial
AUST R: 10509
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Updated: 06-09-2023
DBL Aciclovir 500mg/20mL Intravenous infusion injection vial
AUST R: 56810
Expected supply: 02 Feb 2024
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply
Updated: 22-08-2023
AUST R: 49945
Expected supply: 31 Jan 2024
Availability: Available
Management action: Alternate brand available
Updated: 11-09-2023
AUST R: 16263
Expected supply: 19 Jan 2024
Availability: Limited Availability
Management action: Alternative generic product is available
Updated: 01-09-2023
FUNNEL WEB SPIDER ANTIVENOM (RABBIT) 125U powder for injection vial
AUST R: 31847
Expected supply: 12 Sep 2023
Availability: Available
Updated: 13-09-2023
AUST R: 42279
Expected supply: 20 Oct 2023
Availability: Available
Management action: The sponsor is closely controlling the supply.
Updated: 19-09-2023
AUST R: 16260
Expected supply: 15 Jan 2024
Availability: Available
Management action: Sponsor is working to expedite the next shipment.
Updated: 21-08-2023
DBL Aciclovir 250mg/10mL Intravenous infusion injection vial
AUST R: 56809
Expected supply: 02 Feb 2024
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Alternative brand available.
Updated: 22-08-2023
SIMULECT basiliximab (rmc) 20mg powder for injection vial and diluent ampoule
AUST R: 66740
Expected supply: 12 Sep 2023
Availability: Available
Updated: 12-09-2023
AUST R: 308715
Expected supply: 30 Oct 2023
Availability: Limited Availability
Management action: Alternative generic product is available
Updated: 01-09-2023
Pertussis filamentous haemagglutinin
AUST R: 106576
Expected supply: 15 Oct 2023
Availability: Limited Availability
Management action: Sponsor is working to expedite the next shipment.
Updated: 14-09-2023
IBIMICYN ampicillin 500mg (as sodium) powder for injection vial
AUST R: 92839
Expected supply: 23 Oct 2023
Availability: Available
Management action: Alternative products available
Updated: 20-09-2023
AUST R: 39954
Expected supply: 30 Nov 2023
Availability: Available
Updated: 07-09-2023
{{headingLabels[selectedTab]}}
Sort by: Updated date | Active ingredient | Trade name | Therapeutic class
URL: http://apps.tga.gov.au/prod/MSI/search/